Milford life sciences company Waters Corp. has announced a new coronavirus test designed for use by researchers studying COVID-19.
“For biomedical and clinical research laboratories that are involved in fighting the pandemic, this kit offers a useful research tool for deeper study of the virus and the versatility to enable pioneering research of other infectious pathogens,” Udit Batra, CEO and president of Waters said in a release.
Waters developed the SARS-CoV-2 LC-MS Kit in support of a coalition of academic, commercial and government research scientists. Their goal was to create a complementary, high-throughput screening method to use different reagents to help relieve strain on the reagent supply chain, according to Waters.
The RUO kit could be used in research studies that include measuring signature peptides of the coronavirus at various stages of infection and future pandemic preparedness studies.
This kit is for research use only and has not been approved for use in clinical diagnostic procedures. This RUO kit has not been tested with clinical samples.
